Intraseason Waning of Influenza Vaccine Effectiveness
- PMID: 30204855
- PMCID: PMC7182205
- DOI: 10.1093/cid/ciy770
Intraseason Waning of Influenza Vaccine Effectiveness
Abstract
Background: In the United States, it is recommended that healthcare providers offer influenza vaccination by October, if possible. However, if the vaccine's effectiveness soon begins to wane, the optimal time for vaccination may be somewhat later. We examined whether the effectiveness of influenza vaccine wanes during the influenza season with increasing time since vaccination.
Methods: We identified persons who were vaccinated with inactivated influenza vaccine from 1 September 2010 to 31 March 2017 and who were subsequently tested for influenza and respiratory syncytial virus (RSV) by a polymerase chain reaction test. Test-confirmed influenza was the primary outcome and days-since-vaccination was the predictor of interest in conditional logistic regression. Models were adjusted for age and conditioned on calendar day and geographic area. RSV was used as a negative-control outcome.
Results: Compared with persons vaccinated 14 to 41 days prior to being tested, persons vaccinated 42 to 69 days prior to being tested had 1.32 (95% confidence interval [CI], 1.11 to 1.55) times the odds of testing positive for any influenza. The odds ratio (OR) increased linearly by approximately 16% for each additional 28 days since vaccination. The OR was 2.06 (95% CI, 1.69 to 2.51) for persons vaccinated 154 or more days prior to being tested. No evidence of waning was found for RSV.
Conclusions: Our results suggest that effectiveness of inactivated influenza vaccine wanes during the course of a single season. These results may lead to reconsideration of the optimal timing of seasonal influenza vaccination.
Keywords: influenza; negative-control outcome; vaccine effectiveness; waning.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Challenges of Vaccine Effectiveness and Waning Studies.Clin Infect Dis. 2019 May 2;68(10):1631-1633. doi: 10.1093/cid/ciy773. Clin Infect Dis. 2019. PMID: 30204853 Free PMC article. No abstract available.
-
Influenza Vaccine Effectiveness.Clin Infect Dis. 2019 Jun 18;69(1):190-191. doi: 10.1093/cid/ciy1084. Clin Infect Dis. 2019. PMID: 30561533 No abstract available.
-
Reply to Ferdinands et al.Clin Infect Dis. 2019 Jun 18;69(1):191-192. doi: 10.1093/cid/ciy1085. Clin Infect Dis. 2019. PMID: 30561559 Free PMC article. No abstract available.
References
-
- Grohskopf LA, Sokolow LZ, Broder KR, et al. . Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016; 65:1–54. - PubMed
-
- World Health Organization. Recommended viruses for influenza vaccines for use in the 2010–2011 northern hemisphere influenza season. Available at: http://www.who.int/influenza/vaccines/virus/2010_11north/en/ Accessed 9 December 2017.
-
- World Health Organization. Recommended composition of influenza virus vaccines for use in the 2011–2012 northern hemisphere influenza season. Available at: http://www.who.int/influenza/vaccines/virus/2011_12north/en/ Accessed 9 December 2017.
-
- Grohskopf LA, Uyeki T, Bressee J, Cox N, Bridges C. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1128–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
